Length of treatment. Three questions for prescribers
- PMID: 20843922
- DOI: 10.1136/bmj.c5013
Length of treatment. Three questions for prescribers
Comment on
-
How long should treatments be continued?BMJ. 2010 Aug 19;341:c4102. doi: 10.1136/bmj.c4102. BMJ. 2010. PMID: 20724403 No abstract available.
Similar articles
-
[Information about prescribed drugs is insufficient].Lakartidningen. 2010 Sep 8-14;107(36):2056. Lakartidningen. 2010. PMID: 21043192 Swedish. No abstract available.
-
Prescribing evidence: the efficacy and safety of new drugs.Am Fam Physician. 2010 Jul 1;82(1):37. Am Fam Physician. 2010. PMID: 20590066 No abstract available.
-
Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.Clin Trials. 2011 Oct;8(5):559-70. doi: 10.1177/1740774511419165. Epub 2011 Aug 30. Clin Trials. 2011. PMID: 21878445 Review.
-
[Assessment of drug treatment in geriatrics with the new FORTA criteria].Dtsch Med Wochenschr. 2011 Jul;136(27):1417-21. doi: 10.1055/s-0031-1281530. Epub 2011 Jun 28. Dtsch Med Wochenschr. 2011. PMID: 21713719 German.
-
Chronic headaches and medication overuse.Intern Emerg Med. 2010 Oct;5 Suppl 1:S7-11. doi: 10.1007/s11739-010-0461-y. Intern Emerg Med. 2010. PMID: 20865468 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources